A New Clinical Trial Design Combining Phases 2 and 3: Sequential Designs with Treatment Selection and a Change of Endpoint
- 1 April 2005
- journal article
- other
- Published by Springer Nature in Drug Information Journal
- Vol. 39 (2) , 109-118
- https://doi.org/10.1177/009286150503900201
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Sequential designs for phase III clinical trials incorporating treatment selectionStatistics in Medicine, 2003
- An improved method of evaluating drug effect in a multiple dose clinical trialStatistics in Medicine, 2001
- Semiparametric Efficiency and its Implication on the Design and Analysis of Group-Sequential StudiesJournal of the American Statistical Association, 1997
- Comparison of the spending function method and the christmas tree correction for group sequential trialsJournal of Biopharmaceutical Statistics, 1996
- Optimal two-stage screening designs for survival comparisonsBiometrika, 1990
- Two-stage selection and testing designs for comparative clinical trialsBiometrika, 1988
- Design and analysis of group sequential tests based on the type I error spending rate functionBiometrika, 1987
- Sample sizes for phase II and phase III clinical trials: An integrated approachStatistics in Medicine, 1986
- Discrete sequential boundaries for clinical trialsBiometrika, 1983
- A Sequential Procedure for Selecting the Population with the Largest Mean from $k$ Normal PopulationsThe Annals of Mathematical Statistics, 1964